Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISM: ReQuest in Stepped Down Management of GERD
NCT00261339Phase 4Completed
- Sponsor
- Takeda
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Takeda. Primary endpoint: GERD symptom score (ReQuest) at 8 weeks. Started Aug 2005; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00261339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261339.